Cyclotron production of 103Pd using a liquid target

Nucl Med Biol. 2023 Mar-Apr:118-119:108328. doi: 10.1016/j.nucmedbio.2023.108328. Epub 2023 Feb 9.

Abstract

Introduction: In this work, we present the first feasibility study on the production of the medically important radionuclide 103Pd via the 103Rh(p,n)103Pd reaction by cyclotron irradiation of a liquid target. Using a liquid target removes the time consuming and complex dissolution process of rhodium post-irradiation due to its chemically inactive nature and thereby will improve the accessibility of this radioisotope.

Methods: Liquid targets made from Rh(NO3)3·×H2O salt dissolved in de-ionized water were irradiated using a 12 MeV beam at the TR13 cyclotron at TRIUMF, Vancouver.

Results: A maximum EOB activity of 1.03 ± 0.05 MBq was achieved with the tested conditions, sufficient for basic radiochemistry studies. An effective separation method using anion exchange chromatography is reported using 1 M HNO3 as an eluent for rhodium (90.1 ± 2.1 % recovery) and a 1:1 mixture of 0.5 M NH3 + NH4Cl palladium eluent (103.8 ± 2.3 % recovery). The solution showed good in-target pressure stability. However, the production efficiency decreased significantly with higher solution concentrations and irradiation lengths which puts into question the scaling potential of this method.

Conclusion: This proof-of-concept study has demonstrated the potential for using liquid targets as complementary production method of 103Pd for research purposes. The liquid target route faces several scaling challenges but can nonetheless improve the availability of 103Pd and consequently aid in widening its utility for radiopharmaceuticals.

Keywords: (103)Pd; Liquid targets; Radioisotope production; Targeted radionuclide therapy; Targetry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclotrons*
  • Radiochemistry / methods
  • Radioisotopes / chemistry
  • Radiopharmaceuticals
  • Rhodium*

Substances

  • Rhodium
  • Radioisotopes
  • Radiopharmaceuticals